Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
125
datasets available to search
ShareScore release 0.9.0
Dataset results
125 results for “tumor marker”
Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer
ClinicalTrials.gov study NCT02723526. IPD Sharing: NO. Countries: 1. Publications: 0.
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
ClinicalTrials.gov study NCT05737953. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
ClinicalTrials.gov study NCT00899132. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
ClinicalTrials.gov study NCT02410603. IPD Sharing: NO. Countries: 1. Publications: 0.
Using Color Doppler US Artifact to Identify Tumor Markers
ClinicalTrials.gov study NCT06166173. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Effect of Interval Aerobic Training and Mindfulness Breathing on Hormonal, Metabolic, and Tumor Markers in Postmenopausal
ClinicalTrials.gov study NCT04471506. IPD Sharing: YES. Countries: 1. Publications: 0.
Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules
ClinicalTrials.gov study NCT05871437. IPD Sharing: NO. Countries: 1. Publications: 0.
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
ClinicalTrials.gov study NCT06015802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor
ClinicalTrials.gov study NCT06863844. IPD Sharing: NO. Countries: 1. Publications: 0.
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC
ClinicalTrials.gov study NCT04800497. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
ClinicalTrials.gov study NCT05826964. IPD Sharing: NO. Countries: 1. Publications: 0.
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
ClinicalTrials.gov study NCT07060950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
ClinicalTrials.gov study NCT06339138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mesothelin as a New Tumor Marker for Ovarian Cancer
ClinicalTrials.gov study NCT00155740. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
ClinicalTrials.gov study NCT05217212. IPD Sharing: NO. Countries: 1. Publications: 0.
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
ClinicalTrials.gov study NCT00568490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
ClinicalTrials.gov study NCT06600802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
ClinicalTrials.gov study NCT03881384. IPD Sharing: NO. Countries: 1. Publications: 0.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03723928. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
ClinicalTrials.gov study NCT07186842. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.